TCW Group’s Fulgent Genetics FLGT Stock Holding History

TCW Group’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Buy	131,400 +4,800	+4%	+$81.4K	0.02%	258
2026 Q1	$2.01M	Sell	126,600 -1,800	-1%	-$39.1K	0.02%	277
2025 Q4	$3.37M	Hold	128,400	–	–	0.02%	220
2025 Q3	$2.9M	Hold	128,400	–	–	0.02%	177
2025 Q2	$2.55M	Buy	128,400 +5,000	+4%	+$97.5K	0.02%	238
2025 Q1	$2.09M	Hold	123,400	–	–	0.02%	248
2024 Q4	$2.28M	Buy	123,400 +3,300	+3%	+$64.4K	0.02%	245
2024 Q3	$2.61M	Hold	120,100	–	–	0.02%	233
2024 Q2	$2.36M	Buy	120,100 +3,500	+3%	+$73.1K	0.02%	243
2024 Q1	$2.53M	Hold	116,600	–	–	0.03%	231
2023 Q4	$3.37M	Hold	116,600	–	–	0.04%	213
2023 Q3	$3.12M	Buy	116,600 +21,600	+23%	+$737K	0.04%	194
2023 Q2	$3.52M	Hold	95,000	–	–	0.04%	197
2023 Q1	$2.97M	Buy	95,000 +1,300	+1%	+$41.8K	0.04%	194
2022 Q4	$2.79M	Sell	93,700 -36	-0%	-$1.29K	0.04%	184
2022 Q3	$3.57M	Buy	93,736 +5,346	+6%	+$268K	0.05%	191
2022 Q2	$4.82M	Buy	+88,390	New	+$4.86M	0.06%	177

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCW Group's FLGT Position: Q2 2026 in Review

TCW Group increased its Fulgent Genetics (FLGT) stake by 3.8% in Q2 2026, buying an estimated $81.4K and bringing the position to 131,400 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #258.

TCW Group first reported a position in FLGT in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.82M in Q2 2022. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

TCW Group held 131,400 shares of Fulgent Genetics worth $2.7M as of Q2 2026.
TCW Group bought 4,800 Fulgent Genetics shares in Q2 2026, an estimated $81.4K.
Fulgent Genetics made up 0.02% of TCW Group's portfolio in Q2 2026, its #258 holding.
TCW Group first reported a position in Fulgent Genetics in Q2 2022 and has held it in 17 quarters since.
TCW Group's Fulgent Genetics position peaked at $4.82M in Q2 2022.
142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.